IOL surgery growth was slightly above expectations but within historical ranges.
The overlapping conferences drew an estimated 12 thousand attendees.
The transaction is expected to close in the first quarter of 2017.
More than a half a million procedures have been performed since SMILE’s introduction in 2011.
The deal calls for $60 million up front, plus milestone payments.
The 2016 conference will be held in conjunction with the Asia-Pacific Academy of Ophthalmology.
Recent FDA approval of Abbott’s Symfony IOL, Zeiss’ SMILE procedure, and Shire’s Xiidra should increase the attention on these products.
We will be located in Booth 2451 in Chicago.
Presenters reported similar outcomes for Europe’s three approved retinal prostheses; LUMINOUS study data revealed extraordinary outcomes for anti-VEGF treatment in Australia.
The Spanish government ordered a PFC supplier in Germany to withdraw its product from the market.
Extended depth of focus (EDOF) IOL designs and early clinical experience dominated the sessions.
A “Shark Tank” session allowed three brave entrepreneurs to pitch their new products.
Roughly 145 attended this year’s meeting, with visual scientists, leading clinicians, entrepreneurs, and corporate business development staff.
Rules would take effect in January 2017; researchers will have 90 days to comply.
The segment is expected to grow at a rate of 4.2 percent through 2021.
Procedures are expected to increase at a rate of 5.5 percent over the next five years.
In previous role, Chang was general manager and senior vice president for Bausch + Lomb Surgical.
He replaces Robert Rosiello, who will remain with the Canadian drugmaker.
He argues that public resentment of excessive price hikes could undermine innovation within the industry.
in a 75-page document, CEO Mark Baum outlines his solution to the US drug pricing crisis.
Company expects to file final PMA module in Q4-2017.
Goal is to reduce the approval timetable to 108 days for 510(k)s and 290 days for PMAs by 2022.
You are not currently logged in.
©2018 Market Scope
Lost your Password